Delivery Order 290000015-HHSA2900014

This is a $10,521,865.50 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) for the development of humanized mouse models for HIV therapeutics. The contract, which does not have a set-aside designation, supports research and development focused on advancing new treatments for HIV/AIDS. As a leading academic medical center...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Fenway Community Health Center, Inc., a non-profit organization, for $149,365.00 to provide biological specimens from HIV-positive men who are under or initiating integrase inhibitor-based antiretroviral therapy. The purpose is to develop and assess retroviral integrase, as integrase strand transfer inhibitor (INSTI)-based regimens are increasing in use and...

The Centers for Disease Control and Prevention (CDC) awarded a $2.24 million definitive contract to the University of California, San Diego (UCSD) on September 10, 2023, for operations and maintenance and development, modernization, and enhancement of the Secure HIV-TRACE application. The contract, which runs through September 10, 2026, is structured as a Time and Materials engagement with no set-aside designation. UCSD will support the Secure HIV-TRACE platform, a critical public health tool...

This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to the prime contractor, Vitalant (doing business as Vitalant Research Institute), a non-profit organization. The $4,856,660.60 firm fixed price purchase order is for a study assessing the predictive value of a panel of questions to identify recent HIV infection in men who have sex with men (MSM) interested in donating blood. The prime contractor, Vitalant, is collaborating with two...

This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, San Francisco (UCSF) for the "PRIDE POPULATION RESEARCH IN IDENTITY AND DISPARITIES FOR EQUALITY" program. The contract has a ceiling value of $48,503.54 and an ultimate completion date of February 14, 2025. UCSF is a prominent academic medical center and research institution that has demonstrated significant capabilities...

This is a firm fixed-price delivery order contract awarded by the Health Resources and Services Administration (HRSA), a civilian agency within the U.S. Department of Health and Human Services, to ABT Global LLC, a subsidiary of the research and consulting firm ABT Associates Inc. The contract has a ceiling value of $1,091,954.00 and is for the provision of "Models of Care and the Ryan White Program," which likely involves research, evaluation, and technical assistance related to the...

The Health Resources and Services Administration awarded a $606.6K firm fixed price contract to the County of San Diego (Medical Care Services Division/Health and Human Services Agency) on September 28, 2023, to provide outpatient Hansen's Disease services at the National Hansen's Disease Program (NHDP) Ambulatory Care Centers in San Diego through September 27, 2028. The contract delivers diagnosis, screening, outpatient treatment, case management, and follow-up care for Hansen's Disease...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $424,219.32 firm fixed price delivery order to Research Support Services (RSS), a research firm, to conduct qualitative inquiry methods to understand issues in HIV prevention, care, and treatment. This delivery order is part of a larger Qualitative Inquiry Methods for HIV Prevention Care and Treatment contract vehicle. RSS has previously conducted research services for various federal agencies,...

This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Atlas Research LLC, an award-winning consulting firm. The contract, valued at $3,399,816.00, is for the provision of qualitative inquiry methods to understand issues in HIV prevention, care and treatment. The contract is a delivery order under the Qualitative Inquiry Methods for HIV Prevention Care and Treatment contract vehicle. It does not have a set-aside designation. Atlas Research LLC has a history...

The Centers for Disease Control and Prevention (CDC) awarded a $4,455,976 cost-no-fee definitive contract to The Regents of the University of California, San Francisco (UCSF) to develop, implement, and evaluate interventions to improve latent tuberculosis infection (LTBI) identification and treatment among high-risk non-U.S.-born populations in primary care settings. This contract, known as Tuberculosis Epidemiologic Studies Consortium III (TBESC3), has a period of performance from September 29,...